Home
About
FAQ
History (14)
Principal Investigator
Vaccinium myrtillus
Response to inadequate dialysis in chronic peritoneal dialysis patients. Results from the 2000 Centers for Medicare and Medicaid (CMS) ESRD Peritoneal Dialysis Clinical Performance Measures (PD-CPM) Project.
Effect of surgical approach to hip arthroplasty on postoperative pain and mobilization and on efficacy of intrathecal oxytocin for pain.
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.
Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 2004 Mar 15; 64(6):2070-5.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Cell Division
Enzyme Inhibitors
Humans
Lactones
Male
Mice
Mice, Nude
Prostatic Neoplasms
Tumor Cells, Cultured
authors with profiles
Steven J. Kridel PhD